Showing results (401-410 of 413) with videos related to
Sort By:
Pageof 42
Mayo Clinic Proceedings|April 13, 2016
Ethnicity, Socioeconomic Status, and Health Disparities in a Mixed Rural-Urban US Community-Olmsted County, MinnesotaChung-Il Wi, Jennifer L St Sauver, Debra J Jacobson, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|September 9, 2014
Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging projectM Elbatarny, S Mollah, J Grabell, et al.MMWR. Morbidity and Mortality Weekly Report|October 30, 2015
Active Bacterial Core Surveillance for Legionellosis - United States, 2011-2013Kathleen L Dooling, Karrie-Ann Toews, Lauri A Hicks, et al.Blood|July 15, 2022
Moderate-intensity aerobic exercise vs desmopressin in adolescent males with mild hemophilia A: a randomized trialRiten Kumar, Amy L Dunn, Jane E Schneiderman, et al.Contemporary Clinical Trials|May 14, 2022
Communication and Activation in Pain to Enhance Relationships and Treat Pain with Equity (COOPERATE): Rationale, study design, methods, and sample characteristicsMarianne S Matthias, Jasma Adams, Diana J Burgess, et al.Infection Control and Hospital Epidemiology|June 11, 2014
On-site availability of Legionella testing in acute care hospitals, United StatesLaurel E Garrison, Kristin M S Shaw, Jeffrey T McCollum, et al.Pain|September 21, 2023
Communication and activation in pain to enhance relationships and treat pain with equity (COOPERATE): a randomized clinical trialMarianne S Matthias, Joanne K Daggy, Anthony J Perkins, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|June 2, 2018
The Jamaican Haemophilia Registry: Describing the burden of diseaseG Wharfe, L Buchner-Daley, T Gibson, et al.The Journal of Pain|February 26, 2025
Equity Using Interventions for Pain and Depression (EQUIPD): A pilot randomized trialMarianne S Matthias, Diana J Burgess, Joanne K Daggy, et al.American Journal of Respiratory and Critical Care Medicine|December 10, 2014
Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertensionRachel Damico, Todd M Kolb, Lidenys Valera, et al.Pageof 42